undefined undefined
NaN.000
NaN.00%
Voyager Therapeutics is up ~8% in after-hour trading Monday after reporting Q1 financial results that beat on the top and bottom lines. In the quarter, the company swung to a loss of $11.3M from net i...
今天 05:41
INGREZZA® (valbenazine) First Quarter Net Product Sales of $506 Million Representing 23% Year-Over-Year Growth INGREZZA® SPRINKLE (valbenazine) Capsules Approved by the U.S. FDA Crinecerfont...
05-01 19:00
Daix (France), Long Island City (New York, United States), March 28, 2024 – Inv...
03-28 15:00
格隆汇3月26日|成分股Summit Therapeutics Plc.涨9.91%领跑,Voyager Therapeutics涨9.34%,Anavex ...
03-26 22:13
12月31日,Voyager Therapeutics, Inc.(VYGR.US)公布财报,公告显示公司2023财年净利润为1.32亿美元,同比增加384....
03-04 00:25
Voyager Therapeutics, Inc. (NASDAQ:VYGR) shareholders have had their patience r...
03-02 08:51
Voyager Therapeutics shares are trading lower following Q4 earnings.
03-01 00:40
Voyager Therapeutics (NASDAQ:VYGR) reported its Q4 earnings results on Wednesda...
02-29 05:30
Voyager Therapeutics (NASDAQ:VYGR) reported quarterly earnings of $1.25 per share which beat the analyst consensus estimate of $(0.29) by 531.03 percent. The company reported quarterly sales of $90.06 million which beat
02-29 05:27